Selected article for: "viral infection and world viral infection"

Author: Bouaziz, JD; Duong, T; Jachiet, M; Velter, C; Lestang, P; Cassius, C; Arsouze, A; Domergue Than Trong, E; Bagot, M; Begon, E; Sulimovic, L; Rybojad, M
Title: Vascular skin symptoms in COVID‐19: a french observational study
  • Cord-id: qreg4emx
  • Document date: 2020_4_27
  • ID: qreg4emx
    Snippet: Coronavirus 19 (COVID‐19) was declared as a pandemic viral infection by the World Health organization on March 11(th) 2020. Usual clinical manifestations of COVID‐19 infection include fever, fatigue, myalgia, headache, diarrhea, dry cough, dyspnea that may lead to acute respiratory distress syndrome and death (1). Skin symptoms of COVID‐19 have been poorly described but may include erythematous rash, urticaria and chicken pox like lesions (2‐7). Angiotensin‐converting enzyme 2 (ACE2) i
    Document: Coronavirus 19 (COVID‐19) was declared as a pandemic viral infection by the World Health organization on March 11(th) 2020. Usual clinical manifestations of COVID‐19 infection include fever, fatigue, myalgia, headache, diarrhea, dry cough, dyspnea that may lead to acute respiratory distress syndrome and death (1). Skin symptoms of COVID‐19 have been poorly described but may include erythematous rash, urticaria and chicken pox like lesions (2‐7). Angiotensin‐converting enzyme 2 (ACE2) is a cellular receptor for COVID‐19.

    Search related documents:
    Co phrase search for related documents
    • abnormal myocardial and lung injury: 1
    • acute death respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute death respiratory distress syndrome lead and lung injury: 1, 2, 3